U.S., Feb. 6 -- ClinicalTrials.gov registry received information related to the study (NCT07389473) titled 'Evaluate the Effects of Long-term Use of Psychotropic Medications on Eye Movement Patterns With the Gaize Device' on Aug. 20, 2025.
Brief Summary: The study aims to verify if the Gaize ocular device can effectively identify eye movements indicative of prescribed psychotropic medication usage by employing Drug Recognition Expert (DRE) testing protocols within a controlled virtual environment.
Study Start Date: April 17, 2024
Study Type: OBSERVATIONAL
Condition:
ADHD
Depression Disorders
Mood Disorders
Anxiety Disorder Generalized
Bipolar Disorder (BPD)
Intervention:
DRUG: Prescription Psychotropic Medications
Currently using a ...